Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W H Frishman

Showing results (11-20 of 311) with videos related to

Pageof 32
Sort By:
Journal of Clinical Pharmacology|December 1, 1994
Calcium-channel entry blocker therapy for hypertensive patients with concomitant renal impairment: a focus on isradipineW H Frishman
The American Journal of Cardiology|April 2, 1992
Comparative pharmacokinetic and clinical profiles of angiotensin-converting enzyme inhibitors and calcium antagonists in systemic hypertensionW H Frishman
Journal of Cardiovascular Pharmacology|January 1, 1991
The interplay of ischemic and hypertensive pathophysiology on cardiac functionW H Frishman
Hypertension (Dallas, Tex. : 1979)|March 1, 1988
Beta-adrenergic receptor blockers. Adverse effects and drug interactionsW H Frishman
Cardiovascular Drugs and Therapy|September 1, 1988
Properties of labetalol, a combined alpha- and beta-blocking agent, relevant to the treatment of myocardial ischemiaW H Frishman
The American Journal of Cardiology|May 15, 1987
Beta-adrenergic blocker withdrawalW H Frishman
Hospital Practice (Hospital Ed.)|May 1, 1982
Antiplatelet therapy in coronary heart diseaseW H Frishman
Current Problems in Cardiology|February 7, 2001
Recent advances in cardiovascular pharmacologyW H Frishman
Heart Disease (Hagerstown, Md.)|December 1, 2001
Increased vascular compliance/decreased cardiovascular risk: what the studies tell usW H Frishman
Clinical Cardiology|June 1, 1990
The efficacy and safety of quinapril in the treatment of moderate to severe and severe hypertension: comparison to captoprilW H Frishman
Pageof 32

Showing results (11-20 of 311) with videos related to

Sort By:
Pageof 32
Journal of Clinical Pharmacology|December 1, 1994
Calcium-channel entry blocker therapy for hypertensive patients with concomitant renal impairment: a focus on isradipineW H Frishman
The American Journal of Cardiology|April 2, 1992
Comparative pharmacokinetic and clinical profiles of angiotensin-converting enzyme inhibitors and calcium antagonists in systemic hypertensionW H Frishman
Journal of Cardiovascular Pharmacology|January 1, 1991
The interplay of ischemic and hypertensive pathophysiology on cardiac functionW H Frishman
Hypertension (Dallas, Tex. : 1979)|March 1, 1988
Beta-adrenergic receptor blockers. Adverse effects and drug interactionsW H Frishman
Cardiovascular Drugs and Therapy|September 1, 1988
Properties of labetalol, a combined alpha- and beta-blocking agent, relevant to the treatment of myocardial ischemiaW H Frishman
The American Journal of Cardiology|May 15, 1987
Beta-adrenergic blocker withdrawalW H Frishman
Hospital Practice (Hospital Ed.)|May 1, 1982
Antiplatelet therapy in coronary heart diseaseW H Frishman
Current Problems in Cardiology|February 7, 2001
Recent advances in cardiovascular pharmacologyW H Frishman
Heart Disease (Hagerstown, Md.)|December 1, 2001
Increased vascular compliance/decreased cardiovascular risk: what the studies tell usW H Frishman
Clinical Cardiology|June 1, 1990
The efficacy and safety of quinapril in the treatment of moderate to severe and severe hypertension: comparison to captoprilW H Frishman
Pageof 32